EVGN (Evogene) Valuation Rank


EVGN Evogene Ltd EVGN
33 GF Score
Price $0.44
GF Value $0.44
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Evogene Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Evogene Valuation Rank Related Terms

EVGN
33GF Score
Evogene Ltd EVGN
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Evogene (EVGN) Overvalued in 2026?

Based on GuruFocus' analysis, Evogene stock appears to be undervalued. The current stock price of $0.44 is trading 0.5% below its estimated GF Value™ of $0.44. GuruFocus considers Evogene to be Fairly Valued.

Key valuation signals for EVGN:

  • Valuation Rank:
  • GF Value™: $0.44 vs. price of $0.44 (0.5% below fair value)
  • GF Score™: 33/100 with 7 warning signs

No single metric tells the full story. See the EVGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Evogene Business Description

Other Exchanges EVGN:Israel
Address 13 Gad Feinstein Street, Park Rehovot, Ness Ziona, Rehovot, ISR, 7638517
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.
33GF Score

Get the complete analysis for EVGN

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.44
Price
$0.44
GF Value